Helios Bioelectronics Inc.
Update：2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
1. CMOS-Based Biochip System
Developed in collaboration with TSMC, the CMOS (Complementary Metal-Oxide-Semiconductor) biochip system is designed for multiplexing, enabling simultaneous detection of multiple biomarkers and rapid collection of extensive biological data. With high-throughput capabilities, this system is ideal for artificial intelligence (AI) analysis and applications in disease diagnosis and drug development. Its high integration and flexibility make it highly promising for precision medicine.
2. Nanowire Field Effect Transistor (FET) System
In partnership with Episil Technologies, Helios developed a nanowire FET system with ultra-high sensitivity for detecting trace biomarkers. This system is particularly suited for high-precision biological detection scenarios, such as early disease diagnosis or tracking specific biomarkers. Its exceptional sensitivity provides a unique advantage in trace analysis.
Developed in collaboration with TSMC, the CMOS (Complementary Metal-Oxide-Semiconductor) biochip system is designed for multiplexing, enabling simultaneous detection of multiple biomarkers and rapid collection of extensive biological data. With high-throughput capabilities, this system is ideal for artificial intelligence (AI) analysis and applications in disease diagnosis and drug development. Its high integration and flexibility make it highly promising for precision medicine.
2. Nanowire Field Effect Transistor (FET) System
In partnership with Episil Technologies, Helios developed a nanowire FET system with ultra-high sensitivity for detecting trace biomarkers. This system is particularly suited for high-precision biological detection scenarios, such as early disease diagnosis or tracking specific biomarkers. Its exceptional sensitivity provides a unique advantage in trace analysis.
Founded Year
2016
Unified Business No.
45120064
Status
Active
Number of Employees
23
Total Paid-in
Capital
136,302,456 (NT$)
Location of Company
Taiwan
, Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Helios Bioelectronics Inc. Company IntroductionFounded in 2016, Helios Bioelectronics Inc. is an innovative biotechnology company dedicated to integrating semiconductor technology with biomarker detection.
The company’s initial goal was to combine advanced semiconductor technology with biological diagnostics to develop efficient and precise diagnostic tools, advancing healthcare and drug development. Through collaborations with Taiwan Semiconductor Manufacturing Company (TSMC) and Episil Technologies, Helios has successfully developed two cutting-edge biochip systems, demonstrating its exceptional capability in merging biotechnology with semiconductor technology.
The company’s initial goal was to combine advanced semiconductor technology with biological diagnostics to develop efficient and precise diagnostic tools, advancing healthcare and drug development. Through collaborations with Taiwan Semiconductor Manufacturing Company (TSMC) and Episil Technologies, Helios has successfully developed two cutting-edge biochip systems, demonstrating its exceptional capability in merging biotechnology with semiconductor technology.
